Internal Medicine, Endocrinology, Diabetes, & Metabolism · Arecibo, PR
NPI
1659758324
Since 2015
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
11 Calle Ana Lens de Susoni
Arecibo, PR, 00612
Phone (787) 568-3573
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,179
51 services
Medicare patients, 2024
18
Average age 68
Drug cost, 2024
$2.1M
6,430 prescriptions
Company payments, 2025
$47.62
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria D Marrero Mendez was code 99214 (office e&m - established), 35 times for 18 patients. In total Maria D Marrero Mendez billed 51 services in 7 codes, and Medicare paid $3,179.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 35 | 18 | $70.09 | $2,453 |
By year: 2023 $4,522 for 54 services; 2024 $3,179 for 51 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria D Marrero Mendez prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 984 prescriptions and refills. In total Maria D Marrero Mendez wrote 6,430 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 984 | 2,360 | 264 | $95K |
| Rosuvastatin Calcium Generic | 582 | 1,470 | 210 | $10K |
| Metformin Hcl Generic | 187 | 474 | 73 | $1,461 |
| Trulicity Dulaglutide | 183 | 207 | 33 | $204K |
| Atorvastatin Calcium Generic | 182 | 454 | 85 | $2,128 |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 168 | 258 | 41 | $148K |
| Alendronate Sodium Generic | 160 | 349 | 52 | $1,513 |
| Ozempic Semaglutide | 160 | 170 | 24 | $158K |
| Pioglitazone Hcl Generic | 159 | 319 | 49 | $2,961 |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 156 | 276 | 50 | $168K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 155 | 311 | 49 | $16K |
| Farxiga Dapagliflozin Propanediol | 145 | 215 | 42 | $124K |
| Ezetimibe Generic | 137 | 335 | 51 | $2,631 |
| Pen Needle Pen Needle, Diabetic | 133 | 286 | 52 | $5,387 |
| Glipizide Er Glipizide | 125 | 319 | 43 | $3,105 |
Brand drugs: 3,421 claims; generic drugs: 2,616 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria D Marrero Mendez $47.62 ($47.62 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $47.62.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 2 | $47.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.